Literature DB >> 24849324

PharmGKB summary: tramadol pathway.

Li Gong1, Ulrike M Stamer, Mladen V Tzvetkov, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24849324      PMCID： PMC4100774          DOI： 10.1097/FPC.0000000000000057

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  67 in total

1.  Pharmacokinetics of tramadol is affected by MDR1 polymorphism C3435T.

Authors:  Ondrej Slanar; Milan Nobilis; Jaroslav Kvétina; Olga Matousková; Jeffrey R Idle; Frantisek Perlík
Journal:  Eur J Clin Pharmacol       Date:  2007-01-30       Impact factor: 2.953

2.  Codeine and tramadol analgesic efficacy and respiratory effects are influenced by CYP2D6 genotype.

Authors:  U M Stamer; F Stüber
Journal:  Anaesthesia       Date:  2007-12       Impact factor: 6.955

3.  The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype.

Authors:  A Gaedigk; S D Simon; R E Pearce; L D Bradford; M J Kennedy; J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

4.  Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.

Authors:  U M Stamer; F Musshoff; M Kobilay; B Madea; A Hoeft; F Stuber
Journal:  Clin Pharmacol Ther       Date:  2007-03-14       Impact factor: 6.875

5.  Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype.

Authors:  Emilio García-Quetglas; José Ramón Azanza; Belén Sádaba; María José Muñoz; Isabel Gil; Miguel Angel Campanero
Journal:  Pharmacol Res       Date:  2006-11-23       Impact factor: 7.658

6.  Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.

Authors:  GuoXiang Wang; Hui Zhang; FeiFang He; XiangMing Fang
Journal:  Eur J Clin Pharmacol       Date:  2006-09-08       Impact factor: 2.953

7.  Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers.

Authors:  Rasmus Steen Pedersen; Per Damkier; Kim Brøsen
Journal:  Eur J Clin Pharmacol       Date:  2006-06-09       Impact factor: 2.953

8.  Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.

Authors:  Siew Hua Gan; Rusli Ismail; Wan Aasim Wan Adnan; Wan Zulmi
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

9.  Effects of the CYP2D6 gene duplication on the pharmacokinetics and pharmacodynamics of tramadol.

Authors:  Julia Kirchheiner; Jan-Tobias H A Keulen; Steffen Bauer; Ivar Roots; Jürgen Brockmöller
Journal:  J Clin Psychopharmacol       Date:  2008-02       Impact factor: 3.153

10.  Once-daily, controlled-release tramadol and sustained-release diclofenac relieve chronic pain due to osteoarthritis: a randomized controlled trial.

Authors:  A D Beaulieu; P M Peloso; B Haraoui; W Bensen; G Thomson; J Wade; P Quigley; J Eisenhoffer; Z Harsanyi; A C Darke
Journal:  Pain Res Manag       Date:  2008 Mar-Apr       Impact factor: 3.037
View more
  26 in total

1.  Physician's role in prescribing opioids in developing countries.

Authors:  Jorge A Roa; Alexandra Guevara; Carolina Guevara; Jaime Guevara-Aguirre
Journal:  BMJ Case Rep       Date:  2019-06-02

2.  Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study.

Authors:  Karel Allegaert; Nick Holford; Brian J Anderson; Sam Holford; Frank Stuber; Alain Rochette; Iñaki F Trocóniz; Horst Beier; Jan N de Hoon; Rasmus S Pedersen; Ulrike Stamer
Journal:  Clin Pharmacokinet       Date:  2015-02       Impact factor: 6.447

3.  Potential for Drug-Drug Interactions with Adjunctive Tramadol Use in Treatment of Obsessive-Compulsive Disorder.

Authors:  Eric E Brown; Simon Davies
Journal:  Can J Psychiatry       Date:  2016-05       Impact factor: 4.356

4.  Bleeding and Elevated INR Secondary to Concomitant Tramadol and Warfarin Administration.

Authors:  Keith T Veltri; William A Olsufka
Journal:  P T       Date:  2019-09

5.  Tramadol differentially regulates M1 and M2 macrophages from human umbilical cord blood.

Authors:  Jun Zhang; Liang Chen; Yunyun Sun; Yuanhai Li
Journal:  Inflammopharmacology       Date:  2017-03-17       Impact factor: 4.473

Review 6.  New Insights on Tramadol and Immunomodulation.

Authors:  Iqira Saeed; Adam La Caze; Markus W Hollmann; Paul N Shaw; Marie-Odile Parat
Journal:  Curr Oncol Rep       Date:  2021-08-27       Impact factor: 5.075

Review 7.  The Pharmacogenetics of Tramadol.

Authors:  Dorte Lassen; Per Damkier; Kim Brøsen
Journal:  Clin Pharmacokinet       Date:  2015-08       Impact factor: 6.447

8.  Association of tramadol with risk of myocardial infarction among patients with osteoarthritis.

Authors:  J Wei; M J Wood; M Dubreuil; G Tomasson; M R LaRochelle; C Zeng; N Lu; J Lin; H K Choi; G Lei; Y Zhang
Journal:  Osteoarthritis Cartilage       Date:  2019-10-16       Impact factor: 6.576

Review 9.  Personalized pediatric anesthesia and pain management: problem-based review.

Authors:  Senthil Packiasabapathy; Valluvan Rangasamy; Nicole Horn; Michele Hendrickson; Janelle Renschler; Senthilkumar Sadhasivam
Journal:  Pharmacogenomics       Date:  2020-01       Impact factor: 2.533

10.  Evaluation of mitochondrial dysfunction due to oxidative stress in therapeutic, toxic and lethal concentrations of tramadol.

Authors:  Leila Mohammadnejad; Kambiz Soltaninejad; Mohammad Seyedabadi; Seyed Khosro Ghasem Pouri; Mohammad Shokrzadeh; Hamidreza Mohammadi
Journal:  Toxicol Res (Camb)       Date:  2021-11-08       Impact factor: 3.524
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.